Finding studies
Finding studies
Take this into the appointment.
Saves the questions and what to expect into your notes, next to the visit they belong to.
Lead
New York University Cancer Institute
With
OBJECTIVES: * Determine the impact on survival and the antitumor effects of thalidomide in patients with sarcomas or carcinosarcoma (mixed mesodermal tumors) of gynecologic origin. * Determine the safety and side effect profiles of the target dose of this treatment regimen in this patient population. * Determine the antiangiogenic and immunologic effects of this treatment regimen in these patients. OUTLINE: Patients receive oral thalidomide daily. Treatment continues in the absence of disease progression or unacceptable toxicity. Patients are followed every 3 months for 2 years, every 6 months for 3 years, and then annually thereafter. PROJECTED ACCRUAL: A total of 60 patients will be accrued for this study within 18 months.
Age
Any age
Sex
FEMALE
Healthy volunteers
Not accepted
